BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33153388)

  • 21. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic?
    Ruder AD; Smith DL; Madsen MT; Kass FH
    J Oncol Pharm Pract; 2011 Dec; 17(4):425-32. PubMed ID: 21248174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients.
    Umar RM; Apikoglu-Rabus S; Yumuk PF
    Int J Clin Pharm; 2020 Apr; 42(2):652-661. PubMed ID: 32078106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacist value-added to neuro-oncology subspecialty clinics: A pilot study uncovers opportunities for best practices and optimal time utilization.
    Lee GW; Mathur AD; Andrick BJ; Leese E; Zally D; Gatson NTN
    J Oncol Pharm Pract; 2020 Dec; 26(8):1937-1941. PubMed ID: 32938297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network.
    Booth JP; Kennerly-Shah JM; Kelley LR; Capozzi D; Prescott HA; Soefje SA; Pace MB; Barbour SY; Tizon RF; DeVincenzo S; Carnes CA; Neidecker MV
    J Oncol Pharm Pract; 2023 Dec; 29(8):1907-1914. PubMed ID: 36803319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
    de Grégori J; Pistre P; Boutet M; Porcher L; Devaux M; Pernot C; L Chrétien M; Rossi C; Manfredi S; Dalac S; Gueneau P; Boulin M
    J Oncol Pharm Pract; 2020 Jul; 26(5):1172-1179. PubMed ID: 32299314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
    Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
    JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of early in-hospital medication review by clinical pharmacists on health services utilization.
    Hohl CM; Partovi N; Ghement I; Wickham ME; McGrail K; Reddekopp LN; Sobolev B
    PLoS One; 2017; 12(2):e0170495. PubMed ID: 28192477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impacts of Pharmacists-Managed Oncology Outpatient Clinic on Resolving Drug-Related Problems in Ambulatory Neoplasm Patients: A Prospective Study in China.
    Zhao X; Xu R; Wang Y; Zhu W; Hu H; Shen Z; Guo C; Zhang J
    Inquiry; 2021; 58():469580211009662. PubMed ID: 33847148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacy services in an ambulatory oncology clinic: Patient perception and satisfaction.
    Munro L; Myers G; Gould O; LeBlanc M
    J Oncol Pharm Pract; 2021 Jul; 27(5):1086-1093. PubMed ID: 32842862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The DE-PHARM Project: A Pharmacist-Driven Deprescribing Initiative in a Nursing Facility.
    Pruskowski J; Handler SM
    Consult Pharm; 2017 Aug; 32(8):468-478. PubMed ID: 29029668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes assessment of a pharmacist-directed seamless care program in an ambulatory oncology clinic.
    Edwards SJ; Abbott R; Edwards J; LeBlanc M; Dranitsaris G; Donnan J; Laing K; Whelan MA; MacKinnon NJ
    J Pharm Pract; 2014 Feb; 27(1):46-52. PubMed ID: 24065784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Survey of the Efficacy of Long-term and Successive Pharmaceutical Care in Outpatient Chemotherapy by Oncology Pharmacy Specialists].
    Saito Y; Harada S; Kobayashi M; Ueda K; Yamazaki K; Kumai M; Miyamoto T; Kasashi K; Yamada T; Komatsu Y; Iseki K
    Yakugaku Zasshi; 2018; 138(11):1409-1416. PubMed ID: 30381649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of a community-based pharmacist-run attention deficit hyperactivity disorder clinic in a college health center.
    Pohl L; El-Kurdi R; Selinger R; Sauls A; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2021; 61(4S):S178-S183. PubMed ID: 33676837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure.
    Kalista T; Lemay V; Cohen L
    J Am Pharm Assoc (2003); 2015; 55(4):438-42. PubMed ID: 26161487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of an Oncology Clinical Pharmacist Specialist in an Outpatient Multiple Myeloma Clinic.
    Virani A; Schlei Z; Gleason C; Ackermann M; Wolfe B; Major S; McIver A; Jakubowiak AJ; Jasielec J; Parsad S
    Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):e543-e546. PubMed ID: 32605900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Educational needs of oncology pharmacists: A survey by the International Society of Oncology Pharmacy Practitioners.
    Patel H; Tan CJ; Toh YL; Danilak M; Alexander M
    J Oncol Pharm Pract; 2021 Apr; 27(3):623-634. PubMed ID: 32539662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study.
    Schnipper JL; Roumie CL; Cawthon C; Businger A; Dalal AK; Mugalla I; Eden S; Jacobson TA; Rask KJ; Vaccarino V; Gandhi TK; Bates DW; Johnson DC; Labonville S; Gregory D; Kripalani S;
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):212-9. PubMed ID: 20233982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming the Medication Regimen Review Process Using Telemedicine to Prevent Adverse Events.
    Kane-Gill SL; Wong A; Culley CM; Perera S; Reynolds MD; Handler SM; Kellum JA; Aspinall MB; Pellett ME; Long KE; Nace DA; Boyce RD
    J Am Geriatr Soc; 2021 Feb; 69(2):530-538. PubMed ID: 33233016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Discharge Anticoagulation Education by Emergency Department Pharmacists at a Tertiary Academic Medical Center.
    Zdyb EG; Courtney DM; Malik S; Schmidt MJ; Lyden AE
    J Emerg Med; 2017 Dec; 53(6):896-903. PubMed ID: 28941557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Project EVADE: Evaluating the effects of a pharmacist-run transitions of care clinic on hospital readmissions.
    Brauner MS; Accursi ML; Cantillo SL; Baxter MV; Burant CJ
    J Am Pharm Assoc (2003); 2020; 60(3):503-508. PubMed ID: 31866388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.